October is Breast Cancer Awareness Month. A time when organizations and individuals worldwide unite in their efforts to raise attention about breast cancer and promote early detection, prevention, and treatment.
IDEVAX proudly joins this global initiative to increase public mindfulness of this pervasive disease and to emphasize the importance of cutting-edge advancements in breast cancer care.
This year, IDEVAX is delighted to announce the publication of a White Paper. It explores innovations in lymphoscintigraphy and sentinel lymph node mapping for breast cancer patients.
Lymphoscintigraphy, in conjunction with sentinel lymph node mapping, plays a pivotal role in breast cancer management. Identifying the sentinel lymph node(s) allows physicians to determine the extent of cancer spread and tailor treatment plans accordingly.
Read the full White Paper here “Innovative intradermal injection device for lymphoscintigraphy and sentinel lymph node mapping”
🎗️ Think Pink 🎗️